Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290819 ((S)-4-(3-(2H-1,2,3-triazol-2-yl)phenylamino)-2-(1-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM291025 ((S)-2-(2-aminobutylamino)-4-(1-ethyl-1H-indol-4-yl...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290647 (2-((1R,2S)-2-aminocyclohexylamino)-4-(3-(thiazol-4...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290649 (2-((1R,2S)-2-aminocyclohexylamino)-4-(3-(thiazol-2...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290650 (2-((1R,2S)-2-aminocyclohexylamino)-4-(3-(thiazol-5...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290670 (4-(3-(1H-pyrazol-5-yl)phenylamino)-2-((1R,2S)-2-am...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290676 (2-((1R,2S)-2-aminocyclohexylamino)-4-(3-methoxy-5-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290677 (4-(3-(1H-tetrazol-1-yl)phenylamino)-2-((1R,2S)-2-a...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290681 (4-(3-(1H-pyrrol-1-yl)phenylamino)-2-((1R,2S)-2-ami...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290687 (4-(3-(2H-tetrazol-5-yl)phenylamino)-2-((1R,2S)-2-a...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290692 (4-(3-(1H-imidazol-1-yl)phenylamino)-2-((1R,2S)-2-a...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290696 (4-(3-(1H-1,2,3-triazol-1-yl)phenylamino)-2-((1R,2S...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM50400047 (BIIB-057 | CHEMBL2177736 | US9579320, Example 87) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid PDB UniChem Similars | PDB US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290709 (2-((1R,2S)-2-aminocyclohexylamino)-4-(3-methyl-5-(...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290721 (2-((1R,2S)-2-aminocyclohexylamino)-4-(4-(1-methyl-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290724 (2-((1R,2S)-2-aminocyclohexylamino)-4-(4-methoxy-3-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290725 (2-((1R,2S)-2-aminocyclohexylamino)-4-(3-methoxy-5-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290726 (2-((1R,2S)-2-aminocyclohexylamino)-4-(4-methyl-3-(...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290727 (2-((1R,2S)-2-aminocyclohexylamino)-4-(3-methyl-5-(...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290730 (2-((1R,2S)-2-aminocyclohexylamino)-4-(3-(1-methyl-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290737 (4-(1H-indol-6-ylamino)-2-((1R,2S)-2-aminocyclohexy...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290738 (2-((1R,2S)-2-aminocyclohexylamino)-4-(quinolin-6-y...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290752 (2-((1R,2S)-2- aminocyclohexylamino)- 4-(3-oxo-3,4-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290756 (2-((1R,2S)-2- aminocyclohexylamino)- 4-(2-oxo-1,2-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290761 (2-((1R,2S)-2- aminocyclohexylamino)- 4-(quinolin-6...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290762 (2-((1R,2S)-2- aminocyclohexylamino)- 4-(1-methyl-1...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290763 (2-((1R,2S)-2- aminocyclohexylamino)- 4-(1-methyl-1...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290768 (2-((1R,2S)-2- aminocyclohexylamino)- 4-(2-(cyclopr...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290793 (2-((1R,2S)-2-aminocyclohexylamino)-4-(4-methylthio...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290799 (2-((1R,2S)-2-aminocyclohexylamino)-4-(3-(isoxazol-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290810 (2-((1R,2S)-2-aminocyclohexylamino)-4-(6-fluoronaph...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290811 (2-((1R,2S)-2-aminocyclohexylamino)-4-(6-carbamoyln...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290813 (2-((1R,2S)-2-aminocyclohexylamino)-4-(6-(dimethylc...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290815 ((S)-2-(2-aminopropylamino)-4-(3-(pyrimidin-2-yl)ph...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290817 (2-((1R,2S)-2-aminocyclohexylamino)-4-(6-(morpholin...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290818 ((S)-4-(3-(2H-1,2,3-triazol-2-yl)phenylamino)-2-(1-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290819 ((S)-4-(3-(2H-1,2,3-triazol-2-yl)phenylamino)-2-(1-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290820 (2-((1R,2S)-2-aminocyclohexylamino)-4-(2-methyl-2H-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290826 (2-((1R,2S)-2-aminocyclohexylamino)-4-(2-methyl-1H-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290829 (2-((1R,2S)-2-aminocyclohexylamino)-4-(2,3-dihydro-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290836 (2-((1R,2S)-2-aminocyclohexylamino)-4-(3-(2,3-dihyd...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290838 (2-((1R,2S)-2-aminocyclohexylamino)-4-(3-(4-fluorop...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290843 (2-((1R,2S)-2-aminocyclohexylamino)-4-(3-(2,3-dihyd...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290851 (2-((1R,2S)-2-aminocyclohexylamino)-4-(3-(benzo[d][...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290853 (2-((1R,2S)-2-aminocyclohexylamino)-4-(3-(3-methyls...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290874 (2-((1R,2S)-2-aminocyclohexylamino)-4-(3-vinylpheny...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290890 (2-((3R,4R)-3-aminotetrahydro-2H-pyran-4-ylamino)-4...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290995 ((R)-2-(2-amino-3-methoxypropylamino)-4-(1-methyl-1...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290996 ((R)-2-(2-amino-3-methylbutylamino)-4-(1-methyl-1H-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Tyrosine-protein kinase SYK (Homo sapiens (Human)) | BDBM290997 (2-((2R,3R)-2-amino-3-methoxylbutylamino)-4-(1-ethy...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
Portola Pharmaceuticals, Inc. US Patent | Assay Description Potency of candidate molecules for inhibiting syk tyrosine phosphorylation activity is assessed by measuring the ability of a test compound to inhibi... | US Patent US9579320 (2017) BindingDB Entry DOI: 10.7270/Q2K07692 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 492 total ) | Next | Last >> |